Skip to main content
. 2017 Mar 24;96(12):e6397. doi: 10.1097/MD.0000000000006397

Figure 3.

Figure 3

Effectiveness of “DCB + BMS strategy” versus “DES alone” or “BMS alone” for treating de novo lesions. Secondary angiographic endpoints: (A) in-segment binary restenosis rate; and (B) in-segment minimum lumen diameter.